EID-1, or "EP300 Interacting Inhibitor of Differentiation 1," is a protein that plays a significant role in the regulation of cell differentiation, a fundamental process in which cells develop into their mature forms and functions. EID-1 acts as a modulator of transcription, influencing the expression of genes involved in cell differentiation pathways.This protein functions by interacting with EP300 (E1A binding protein p300), a well-known transcriptional coactivator involved in a variety of cellular processes including proliferation, differentiation, and apoptosis. EID-1 inhibits the activity of EP300, thereby modulating its role in transcription regulation. Through this interaction, EID-1 indirectly affects the expression of genes that are crucial for the differentiation of cells, particularly in muscle and other tissues.
EID-1's inhibition of EP300 is particularly notable in the context of myogenesis, the process of muscle cell formation. It has been observed to play a role in inhibiting muscle differentiation by interfering with the transcriptional activity necessary for muscle cell development. This inhibition is crucial in maintaining a balance between cell proliferation and differentiation during muscle formation.The regulatory role of EID-1 extends to other cell types and tissues as well, suggesting its broader significance in the process of cellular differentiation. The interaction between EID-1 and EP300 and their subsequent impact on gene expression is a subject of ongoing research, especially in understanding the molecular mechanisms underlying various differentiation processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An inhibitor of histone deacetylase (HDAC), which may indirectly influence EID-1 activity by altering chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting EID-1 activity by altering DNA methylation and gene expression patterns. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another HDAC inhibitor, which could indirectly influence EID-1 by affecting chromatin remodeling and gene expression. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
A selective HDAC3 inhibitor, potentially impacting EID-1 activity through changes in gene expression and chromatin structure. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
A well-known HDAC inhibitor, which may have an indirect effect on EID-1 through epigenetic modifications. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective HDAC inhibitor, which might influence EID-1 activity by modulating gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
An HDAC inhibitor, potentially affecting EID-1 activity through epigenetic changes and gene expression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
A selective HDAC inhibitor, potentially impacting EID-1 through alterations in chromatin and gene expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A potent HDAC inhibitor, which could indirectly influence EID-1 by affecting gene expression and chromatin structure. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
An HDAC inhibitor, potentially affecting EID-1 activity by modulating gene expression patterns. |